Claudia Sandomenico Selected Research

raltitrexed (D 1694)

3/2011

Oxaliplatin plus dual inhibition of thymidilate synthase during preoperative pelvic radiotherapy for locally advanced rectal carcinoma: long-term outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Sandomenico Research Topics

Disease

14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2020 - 01/2011
8	Neoplasms (Cancer) 10/2022 - 03/2014
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2017
6	Colorectal Neoplasms (Colorectal Cancer) 03/2011 - 09/2006
3	Diarrhea 01/2016 - 09/2006
2	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2017
2	Circulating Neoplastic Cells 01/2022 - 11/2012
2	Disease Progression 01/2022 - 07/2013
2	Lung Neoplasms (Lung Cancer) 07/2020 - 10/2019
2	Hemorrhage 01/2020 - 01/2016
2	Vomiting 01/2019 - 09/2006
2	Adenocarcinoma 09/2017 - 01/2016
2	Stomatitis 01/2008 - 09/2006
1	Melanoma (Melanoma, Malignant) 10/2022
1	Adenocarcinoma of Lung 01/2022
1	Deglutition Disorders (Dysphagia) 01/2019
1	Alopecia (Baldness) 01/2019
1	Nausea 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019
1	Hypertension (High Blood Pressure) 01/2016
1	Pruritus (Itching) 06/2012
1	Jaundice (Icterus) 06/2012
1	Cholangitis 06/2012
1	Thrombosis (Thrombus) 03/2011
1	Neutropenia 03/2011
1	Carcinoma (Carcinomatosis) 03/2011
1	Margins of Excision 03/2011
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2011
1	Stomach Neoplasms (Stomach Cancer) 10/2009
1	Colonic Neoplasms (Colon Cancer) 01/2008

Drug/Important Bio-Agent (IBA)

6	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2011 - 09/2006
5	Fluorouracil (Carac)FDA LinkGeneric 03/2011 - 09/2006
5	Leucovorin (Folinic Acid)FDA Link 03/2011 - 09/2006
4	PlatinumIBA 09/2020 - 07/2013
4	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2008
4	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2011
4	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 07/2013
4	Gefitinib (Iressa)FDA Link 01/2014 - 01/2011
4	Irinotecan (Camptosar)FDA LinkGeneric 03/2011 - 09/2006
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 01/2014
3	Tyrosine Kinase InhibitorsIBA 01/2014 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2014
2	Angiogenesis InhibitorsIBA 01/2021 - 01/2020
2	pembrolizumabIBA 09/2020 - 10/2019
2	nintedanibIBA 09/2017 - 01/2016
2	Docetaxel (Taxotere)FDA Link 09/2017 - 01/2016
2	Gemcitabine FDA Link 03/2014 - 07/2013
2	Capecitabine (Xeloda)FDA Link 07/2008 - 01/2008
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2022
1	TrabectedinIBA 01/2022
1	PM 01183IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	big gastrinIBA 01/2021
1	NivolumabIBA 09/2020
1	Monoclonal AntibodiesIBA 07/2020
1	atezolizumabIBA 07/2020
1	RamucirumabIBA 01/2020
1	B7-H1 AntigenIBA 10/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2017
1	EnzymesIBA 01/2016
1	AfatinibIBA 01/2016
1	Pemetrexed (MTA)FDA Link 03/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2013
1	Cetuximab (Erbitux)FDA Link 02/2012
1	raltitrexed (D 1694)IBA 03/2011
1	AcidsIBA 10/2009
1	Platinum Compounds (Compounds, Platinum)IBA 02/2009
1	ProdrugsIBA 01/2008
1	XELOXIBA 01/2008
1	Cholinergic Agents (Cholinergics)IBA 09/2006

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 10/2022 - 07/2008
4	Therapeutics 01/2022 - 07/2013
2	Immunotherapy 10/2022 - 09/2020
2	Radiotherapy 01/2017 - 03/2011
1	Intravenous Infusions 01/2020
1	Pancreaticoduodenectomy 06/2012
1	Neoadjuvant Therapy 06/2012
1	Drug Tapering 03/2011
1	Catheters 03/2011